Dopamine Oxidation and Autophagy

The molecular mechanisms involved in the neurodegenerative process of Parkinson's disease remain unclear. Currently, there is a general agreement that mitochondrial dysfunction, α-synuclein aggregation, oxidative stress, neuroinflammation, and impaired protein degradation are involved in the neurodegeneration of dopaminergic neurons containing neuromelanin in Parkinson's disease. Aminochrome has been proposed to play an essential role in the degeneration of dopaminergic neurons containing neuromelanin by inducing mitochondrial dysfunction, oxidative stress, the formation of neurotoxic α-synuclein protofibrils, and impaired protein degradation. Here, we discuss the relationship between the oxidation of dopamine to aminochrome, the precursor of neuromelanin, autophagy dysfunction in dopaminergic neurons containing neuromelanin, and the role of dopamine oxidation to aminochrome in autophagy dysfunction in dopaminergic neurons. Aminochrome induces the following: (i) the formation of α-synuclein protofibrils that inactivate chaperone-mediated autophagy; (ii) the formation of adducts with α- and β-tubulin, which induce the aggregation of the microtubules required for the fusion of autophagy vacuoles and lysosomes.

[1]  Peter T. Lansbury,et al.  Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.

[2]  K. Vrana,et al.  Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase , 1998, Journal of neuroscience research.

[3]  S. Tooze,et al.  Microtubules Facilitate Autophagosome Formation and Fusion of Autophagosomes with Endosomes , 2006, Traffic.

[4]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[5]  R. Coccia,et al.  Catecholamines oxidation by xanthine oxidase. , 1997, Biochimica et biophysica acta.

[6]  D. Graham,et al.  Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.

[7]  L. Chia,et al.  Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease , 2005, Journal of Neural Transmission.

[8]  David Park,et al.  Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.

[9]  S. Vatner,et al.  Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion , 2008, Autophagy.

[10]  G. Miller,et al.  Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons , 2009, Molecular Neurobiology.

[11]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[12]  J. Shih,et al.  Molecular Biology of Monoamine Oxidase A and B: Their Role in the Degradation of Serotonin , 2000 .

[13]  J. Segura-Aguilar,et al.  Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies. , 2007, Chemical Research in Toxicology.

[14]  J. Andersen,et al.  Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo , 2010, Neuroscience Letters.

[15]  K. Marcelain,et al.  Copper neurotoxicity is dependent on dopamine‐mediated copper uptake and one‐electron reduction of aminochrome in a rat substantia nigra neuronal cell line , 2001, Journal of neurochemistry.

[16]  S. Ledoux,et al.  Copper·Dopamine Complex Induces Mitochondrial Autophagy Preceding Caspase-independent Apoptotic Cell Death* , 2009, Journal of Biological Chemistry.

[17]  S. Ledoux,et al.  Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity. , 2010, Chemical research in toxicology.

[18]  A. Grimaldi,et al.  Autophagy in invertebrates: insights into development, regeneration and body remodeling. , 2008, Current pharmaceutical design.

[19]  D. Rubinsztein,et al.  The Itinerary of Autophagosomes: From Peripheral Formation to Kiss-and-Run Fusion with Lysosomes , 2008, Traffic.

[20]  L. Zanatta,et al.  Enzymatic dopamine peroxidation in substantia nigra of human brain. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[21]  J. Segura-Aguilar,et al.  On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase. , 1989, Chemico-biological interactions.

[22]  N. Mizushima,et al.  Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. , 2010, Seminars in cell & developmental biology.

[23]  Michael Cascio,et al.  Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells , 2009, Neurobiology of Disease.

[24]  J. Segura-Aguilar,et al.  Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. , 2005, Chemical Research in Toxicology.

[25]  Steve D. M. Brown,et al.  α-Synuclein impairs macroautophagy: implications for Parkinson’s disease , 2010, The Journal of cell biology.

[26]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[27]  C. Chu,et al.  Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells , 2008, Journal of neurochemistry.

[28]  K. Jellinger,et al.  Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease. , 1996, Biochimica et biophysica acta.

[29]  M. Cookson,et al.  DJ-1 regulation of mitochondrial function and autophagy through oxidative stress , 2011, Autophagy.

[30]  C. Welch,et al.  Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects. , 1998, Biochimica et biophysica acta.

[31]  J. Trojanowski,et al.  Reversible Inhibition of α-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations* , 2005, Journal of Biological Chemistry.

[32]  D. Ross,et al.  A Potential Role for Cyclized Quinones Derived from Dopamine, DOPA, and 3,4-Dihydroxyphenylacetic Acid in Proteasomal Inhibition , 2006, Molecular Pharmacology.

[33]  E. Rosengren,et al.  Detection of 5-S-cysteinyldopamine in human brain , 2005, Journal of Neural Transmission.

[34]  C. Thompson,et al.  Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. , 2000, The Journal of pharmacology and experimental therapeutics.

[35]  J. Segura-Aguilar,et al.  Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition. , 2008, Chemical research in toxicology.

[36]  R. M. Rose,et al.  Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem , 1988, Neuroscience.

[37]  B. Mannervik,et al.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. , 1997, The Biochemical journal.

[38]  R. Youle,et al.  Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.

[39]  Alberto Gatti,et al.  The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease , 2002, FEBS letters.

[40]  H. Yang,et al.  Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y , 2011, Neuroscience.

[41]  D. Selkoe,et al.  Dopamine covalently modifies and functionally inactivates parkin , 2005, Nature Medicine.

[42]  J. Segura-Aguilar,et al.  Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  Y. Akao,et al.  Neuromelanin selectively induces apoptosis in dopaminergic SH‐SY5Y cells by deglutathionylation in mitochondria: involvement of the protein and melanin component , 2008, Journal of neurochemistry.

[44]  J. Segura-Aguilar,et al.  Superoxide dismutase and catalase enhance autoxidation during one-electron reduction of aminochrome by NADPH-cytochrome P-450 reductase. , 1995, Biochemical and molecular medicine.

[45]  J. Segura-Aguilar,et al.  Aminochrome Induces Disruption of Actin, Alpha-, and Beta-Tubulin Cytoskeleton Networks in Substantia-Nigra-Derived Cell Line , 2010, Neurotoxicity Research.

[46]  P. Riederer,et al.  Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease , 2009, Neurotoxicity Research.

[47]  J. Segura-Aguilar,et al.  Monoamine transporter inhibitors and norepinephrine reduce dopamine‐dependent iron toxicity in cells derived from the substantia nigra , 2005, Journal of neurochemistry.

[48]  T. Hastings Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase , 1995, Journal of neurochemistry.

[49]  The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1 , 2012, BioMetals.

[50]  M. T. Herrero,et al.  On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation , 2004, Neurobiology of Disease.

[51]  B. Mannervik,et al.  Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. , 2000, Biochemical and biophysical research communications.

[52]  J. B. Justice,et al.  Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter , 2001, Journal of neurochemistry.

[53]  D. Njus,et al.  Stoichiometry of H+-linked dopamine transport in chromaffin granule ghosts. , 1981, Biochemistry.

[54]  J. Segura-Aguilar Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome. , 1996, Biochemical and molecular medicine.

[55]  T. Myöhänen,et al.  Distribution of catechol‐O‐methyltransferase (COMT) proteins and enzymatic activities in wild‐type and soluble COMT deficient mice , 2010, Journal of neurochemistry.

[56]  C. Welch,et al.  Human Class Mu Glutathione Transferases, in Particular Isoenzyme M2-2, Catalyze Detoxication of the Dopamine Metabolite Aminochrome* , 1997, The Journal of Biological Chemistry.

[57]  Kostas Vekrellis,et al.  Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.

[58]  D. Sulzer,et al.  Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease , 2009, Neurotoxicity Research.

[59]  B. Xia,et al.  Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease. , 1996, Chemical research in toxicology.

[60]  K. Fujita,et al.  Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection. , 1984, Journal of chromatography.

[61]  W. Whisler,et al.  Catecholamine oxidation and ionization properties indicated from the H+ release, tritium exchange, and spectral changes which occur during ferricyanide oxidation. , 1968, Biochemistry.

[62]  Peter T Lansbury,et al.  Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. , 2008, The Journal of clinical investigation.

[63]  E. Rosengren,et al.  The neuromelanin of the human substantia nigra. , 1991, Biochimica et biophysica acta.

[64]  X. Breakefield,et al.  Biochemistry and genetics of monoamine oxidase. , 1990, Pharmacology & therapeutics.

[65]  B. Bergamasco,et al.  Is neuromelanin changed in Parkinson’s disease? Investigations by magnetic spectroscopies , 2006, Journal of Neural Transmission.

[66]  Xiongwei Zhu,et al.  Parkinson’s disease‐associated DJ‐1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction , 2012, Journal of neurochemistry.

[67]  J. Segura-Aguilar,et al.  Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. , 2012, Biochimica et biophysica acta.

[68]  E. Jung,et al.  Autophagy protects the rotenone-induced cell death in α-synuclein overexpressing SH-SY5Y cells , 2010, Neuroscience Letters.

[69]  A. Napolitano,et al.  Oxidation chemistry of catecholamines and neuronal degeneration: an update. , 2011, Current medicinal chemistry.

[70]  M. Schultzberg,et al.  Distribution of dt diaphorase in the rat brain: Biochemical and immunohistochemical studies , 1988, Neuroscience.

[71]  J. Segura-Aguilar,et al.  Protective Effects of Nicotine Against Aminochrome-Induced Toxicity in Substantia Nigra Derived Cells: Implications for Parkinson’s Disease , 2012, Neurotoxicity Research.

[72]  K. Wada,et al.  Aberrant Interaction between Parkinson Disease-associated Mutant UCH-L1 and the Lysosomal Receptor for Chaperone-mediated Autophagy* , 2008, Journal of Biological Chemistry.

[73]  F. Fonnum,et al.  Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances. , 2008, Annual review of pharmacology and toxicology.

[74]  V. Faundez,et al.  A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles , 2009, The Journal of Biological Chemistry.